(1)
Hanumant Gambhire; Monica Gulati; Sachin Kumar Singh; Atul Nasa; Neelu Goel. AN OVERVIEW OF US FDA WARNING LETTERS TO INDIAN PHARMACEUTICAL INDUSTRIES FOR CGMP VIOLATIONS PERTAINING TO STERILE PRODUCTS. J Popl Ther Clin Pharmacol 2022, 29 (03), 1845-1863. https://doi.org/10.53555/jptcp.v29i03.7242.